Trademark Overview
On Monday, November 30, 2015, a trademark application was filed for BIOAVAILABILITY OPTIMIZATION TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the BIOAVAILABILITY OPTIMIZATION TECHNOLOGY trademark a serial number of 86834240. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 14, 2016. This trademark is owned by CritiTech Drug Development Services, LLC. The BIOAVAILABILITY OPTIMIZATION TECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research services; Pharmaceutical research and development, namely, screening drug targets; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of drug development; Conducting scientific feasibility studies; Pharmaceutical research services, namely, screening and identifying optimal active pharmaceutical ingredient (API) forms, optimized final dosing forms, dosing profiles, optimal formulation of pharmaceutical products, determination of drug substance state for enhanced bioavailability, ingredient compatibility screening, solid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product development, optimization of optimal active pharmaceutical ingredient (API) design, formulation of pharmaceutical products and drug product design
